↓ Skip to main content

Cochrane Database of Systematic Reviews

Phenytoin for neuropathic pain and fibromyalgia in adults

Overview of attention for article published in Cochrane database of systematic reviews, May 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy
1 policy source
twitter
12 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
144 Mendeley
Title
Phenytoin for neuropathic pain and fibromyalgia in adults
Published in
Cochrane database of systematic reviews, May 2012
DOI 10.1002/14651858.cd009485.pub2
Pubmed ID
Authors

Fraser Birse, Sheena Derry, R Andrew Moore

Abstract

Antiepileptic drugs have been used in pain management since the 1960s; some have shown efficacy in treating different neuropathic pain conditions. Phenytoin is an established antiepileptic drug that has been used occasionally to treat intractable trigeminal neuralgia.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Spain 1 <1%
Australia 1 <1%
Unknown 140 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 21%
Student > Postgraduate 18 13%
Student > Bachelor 16 11%
Researcher 15 10%
Other 9 6%
Other 30 21%
Unknown 26 18%
Readers by discipline Count As %
Medicine and Dentistry 67 47%
Nursing and Health Professions 13 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Neuroscience 7 5%
Psychology 4 3%
Other 14 10%
Unknown 31 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2022.
All research outputs
#2,266,970
of 22,270,761 outputs
Outputs from Cochrane database of systematic reviews
#4,841
of 12,226 outputs
Outputs of similar age
#13,609
of 144,690 outputs
Outputs of similar age from Cochrane database of systematic reviews
#22
of 87 outputs
Altmetric has tracked 22,270,761 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,226 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,690 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.